The Medicines & Healthcare products Regulatory Agency (MHRA) of UK has approved India-based Ajanta Pharma’s formulation manufacturing plant at Paithan, Aurangabad, India. Ajanta’s Paithan manufacturing plant has also got the US Food and Drug Administration (FDA) approval earlier.Additionally, Ajanta’s Paithan facility also holds the WHO Pre-qualification approval from WHO Geneva.Ajanta Pharma managing director Yogesh Agrawal said they continue to build expertise in the quality standards and approvals from the most stringent regulatory authorities like US, UK and WHO Pre-qualification are testimony to their commitment towards quality.
MHRA approves Ajanta Pharma Paithan manufacturing plant
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Media Packs
Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!
– Access the Media Pack Now
– Book a Conference Call
– Leave Message for Us to Get Back
Related stories
Press Releases
New Syngene biologics manufacturing facility to be operational for US and European customers from mid-year
At DCAT 2024 global bio/pharmaceutical manufacturing forum, Syngene International,...
News
ST Pharm breaks ground on 2nd oligonucleotide manufacturing plant
ST Pharm said it has taken its first step...
BioPharma
Elevating Biopharmaceutical Projects With The Right CDMO
In the biopharma industry, selecting the right contract development...
News
Biovian announces over €50 million investment in manufacturing facility in Turku, Finland
Biovian, a leading contract development and manufacturing organization (CDMO)...
Latest stories
